Globenewswire·2025-09-11 12:00Core Insights - Royal Philips and Masimo have renewed their multi-year strategic collaboration to enhance patient monitoring solutions, focusing on innovation and access to high-quality care [1][5] - The partnership aims to integrate Masimo's advanced monitoring technologies into Philips' patient monitoring platforms, improving data reliability and clinician decision-making [2][5] - Both companies are committed to developing next-generation monitoring solutions that address emerging clinical needs and market demands, including AI algorithms for improved patient care [3][4] Group 1: Partnership Details - The renewed collaboration emphasizes the integration of Masimo's technologies, such as SET® pulse oximetry and Radius PPG, into Philips' monitoring systems [2][5] - The partnership seeks to reduce complexity and enhance interoperability within healthcare systems, allowing clinicians to utilize preferred measurement technologies [2][5] Group 2: Strategic Goals - The collaboration is focused on advancing smart, connected care and expanding access to innovative technologies, reflecting a shared commitment to meaningful innovation [3][5] - Both companies aim to deliver integrated, clinically validated solutions that meet the needs of healthcare providers, aligning with Philips' broader strategy for operational efficiency and vendor-neutral interoperability [5][6] Group 3: Company Background - Royal Philips is a leading health technology company with a focus on improving health and well-being through innovation, generating EUR 18 billion in sales in 2024 [7] - The company employs approximately 69,300 people and operates in over 100 countries, specializing in diagnostic imaging, monitoring, and personal health solutions [7]